U.S. Luxury Stock News

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...

Wondering if Alliant Energy’s current share price reflects its real worth, or if you might be paying too much for a regulated utility stock right now? The stock last closed at US$68.71, with a 7 day return of a 5.6% decline, a 30 day return of a 1.2% decline, a 1 year return of 12.5%, a 3 year return of 46.9%, and a 5 year return of 49.7%. These moves have come as investors continue to reassess regulated utilities as an income and stability option. Alliant Energy has attracted attention as...

Aveanna Healthcare Holdings (NasdaqGS:AVAH) announced the acquisition of Family First Homecare. The deal is intended to strengthen Aveanna's position in Florida and widen its geographic reach. The company also outlined a transformation that increased preferred payer agreements and set new M&A priorities for 2026. Aveanna Healthcare focuses on home based care services, an area many investors watch as care delivery shifts closer to the home. By adding Family First Homecare, the company is...

If you are wondering whether Enerpac Tool Group at around US$35.97 is a bargain, fairly priced, or looking stretched, this article walks through the key valuation angles to help you frame that question clearly. The stock is roughly flat over the last week with a 0.3% return. That sits against a 14.7% decline over the last month and a 14.8% decline over the last year, even as the 3 year and 5 year returns are 37.7% and 38.0% respectively. Recent coverage has focused on how Enerpac Tool Group...

Wondering if First Mid Bancshares at around US$39.44 is giving you fair value or a potential bargain? This article breaks down what the current price might be implying about the business. The stock is roughly flat over the last week at 0.1%, has seen a 9.2% decline over the past month, yet is still up 2.1% year to date and 15.5% over the last year, with a 59.7% return across three years and 0.4% over five years. Recent coverage around regional banks has focused on how share prices react to...

Wondering if Rezolve AI at US$2.53 is still priced for a turnaround or already baking in the story? This breakdown will help you frame what the current market price may be implying. The stock has been volatile recently, with a 5.9% decline over the last week, a 13.5% gain over the last month, an 11.8% year to date drop, and a 53.3% return over the past year, all set against a 74.9% decline over three years. Recent coverage has focused on Rezolve AI as an emerging player in the listed AI...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

FedEx Q3 2026 Earnings Snapshot FedEx (FDX) has put up another solid set of quarterly numbers, with Q3 2026 revenue at US$24.0 billion and basic EPS of US$4.47, giving investors a clear look at how the business is performing through the current fiscal year. The company has seen revenue move from US$21.2 billion in Q3 2025 to US$24.0 billion in Q3 2026, while quarterly basic EPS shifted from US$3.78 to US$4.47 over the same period. The trailing twelve month net profit margin now sits at 4.9%...

JinkoSolar Holding (NYSE:JKS) has entered a multi year supply agreement with Nextpower for U.S. manufactured steel module frames. The partnership centers on steel frames and deeper localization of JinkoSolar's U.S. solar module supply chain. The agreement supports JinkoSolar's efforts to source key components domestically and align with U.S. solar infrastructure priorities. For investors tracking NYSE:JKS, this move comes with the stock at around $23.4 and a mixed performance profile...

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...

United States Antimony (UAMY) has just reported its FY 2025 numbers, with Q4 revenue of about US$13.0 million and a basic EPS loss of roughly US$0.002. Trailing 12 month figures show revenue at around US$39.3 million and a basic EPS loss of about US$0.035. Over the past six reported quarters, revenue has moved from roughly US$2.6 million in Q3 2024 to US$13.0 million in Q4 2025, with quarterly EPS ranging between a profit of about US$0.0048 and a loss of roughly US$0.039. This sets up a...

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...

If you are wondering whether CleanSpark's current share price lines up with its underlying worth, this breakdown will help you connect the stock chart to valuation numbers. CleanSpark closed at US$9.40, with returns of 1.4% over the last 30 days, an 18.6% decline year to date, gains of 26.3% over 1 year, and a very large 3 year return of 249.4%, set against a 55.3% decline over 5 years. Recent coverage has focused on CleanSpark as part of broader commentary on software and tech related...

Darden Restaurants (DRI) just turned in its Q3 2026 scorecard, reporting revenue of US$3.3b and basic EPS of US$2.70. This helps investors weigh the latest quarter against its recent track record. Over the past few periods, revenue has moved from US$3.2b in Q3 2025 to US$3.3b in Q3 2026, while basic EPS went from US$2.76 to US$2.70, giving a clear sense of where the top and bottom lines currently sit. With net profit margin now at 8.7% versus 9.0% a year earlier, the story for this quarter...

If you are wondering whether Andersen Group at US$27.90 is offering fair value or an opportunity, the next sections will walk through what the current price really reflects. The stock has posted returns of 22.2% over the last 7 days, 24.6% over the last 30 days and 14.4% year to date, which has likely caught the eye of investors watching for changing risk and return profiles. Recent coverage has focused on Andersen Group's share price moves and how investors are reassessing the company, with...

BrightSpring Health Services (NasdaqGS:BTSG) is reallocating capital toward acquisitions and organic growth in its core home and clinical services. The company is accelerating de-leveraging efforts to increase financial flexibility. BrightSpring plans to divest its community-living operations, with the transaction expected to close soon. BrightSpring operates in home and clinical care, an area that sits at the intersection of aging demographics, pressure on institutional care settings, and...

If you are wondering whether CBIZ's share price now reflects its true worth, the starting point is understanding how that price lines up against different measures of value. The stock recently closed at US$27.02, with returns of 3.4% over the last week, a 9.5% decline over the past month, and longer term returns of a 46.8% decline year to date and a 63.0% decline over the past year. These moves sit against a backdrop where investors have been reassessing many professional services names,...

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...